beta
PZRX
PhaseRx Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
PhaseRx Inc is a development-stage biotechnology company. It is developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy, or i-ERT.
Market Cap: 3.98 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.phaserx.com
Shares Outstanding: 11.7 Million
Float: 11.6 Million
Dividend: 0.0 (0.0%)
Beta: 5.276227
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 450 trading days
From: 2016-05-26 To: 2018-02-02
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|